CompletedNCT06230757
Psilocybin research study for treatment-resistant depression
About this title
Read the official source — NCT06230757Medication studyAges 21–75United States
Understand this study
Who was this study for?
Listed age limits: 21 years to 75 years.
- Listed locations
- AuroraSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: July 8, 2024
- Recruitment status
- Completed
- Enrollment listed in the registry
- 20
- Sponsor
- University of Colorado, Denver
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 21 Years to 75 Years
- Official registry ID
- NCT06230757
- Official title
Show the full official title
Effects of Psilocybin With Psychological Support on Anhedonia in Treatment-resistant Depression: a Randomized Controlled Pilot Trial
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Aurora
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Colorado, Denver, a university.
Did this study involve medication?
Yes. The study involved medication, including Psilocybin 25mg and Placebo (active placebo).
Who was this study for?
Listed age limits: 21 years to 75 years.
